Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003246821 | SCV003951355 | uncertain significance | Inborn genetic diseases | 2023-03-27 | criteria provided, single submitter | clinical testing | The c.118A>G (p.I40V) alteration is located in exon 1 (coding exon 1) of the WDR62 gene. This alteration results from a A to G substitution at nucleotide position 118, causing the isoleucine (I) at amino acid position 40 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Service de Génétique Moléculaire, |
RCV001255791 | SCV001432405 | likely benign | Microcephaly 2, primary, autosomal recessive, with or without cortical malformations | no assertion criteria provided | clinical testing |